Giacinto Bagetta Selected Research

Aromatherapy

1/2022	Requirements for Translation in Clinical Trials of Aromatherapy: The Case of the Essential Oil of Bergamot (BEO) for Management of Agitation in Severe Dementia.
10/2021	Bergamot rehabilitation AgaINst agitation in dementia (BRAINAID): Study protocol for a randomized, double-blind, placebo-controlled trial to assess the efficacy of furocoumarin-free bergamot loaded in a nanotechnology-based delivery system of the essential oil in the treatment of agitation in elderly affected by severe dementia.
1/2021	Aromatherapy in Stroke Patients: Is it Time to Begin?
4/2020	Role of 5-HT1A Receptor in the Anxiolytic-Relaxant Effects of Bergamot Essential Oil in Rodent.
1/2019	Neuropharmacological Properties of the Essential Oil of Bergamot for the Clinical Management of Pain-Related BPSDs.
9/2018	Antinociceptive effect of inhalation of the essential oil of bergamot in mice.
4/2017	Bergamot Essential Oil Attenuates Anxiety-Like Behaviour in Rats.
1/2017	Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease: Clinical Evidence and Possible Mechanisms.
9/2010	Neuropharmacology of the essential oil of bergamot.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giacinto Bagetta Research Topics

Disease

23	Pain (Aches) 04/2022 - 01/2009
16	Ischemia 01/2017 - 09/2004
14	Brain Ischemia (Cerebral Ischemia) 11/2022 - 09/2004
13	Stroke (Strokes) 01/2022 - 08/2005
12	Glaucoma 06/2022 - 01/2008
10	Dementia (Dementias) 02/2022 - 01/2017
9	Hyperalgesia 01/2022 - 01/2009
9	Ischemic Stroke 01/2019 - 01/2007
8	Brain Injuries (Brain Injury) 11/2022 - 01/2009
8	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2019 - 09/2007
7	Neuralgia (Stump Neuralgia) 01/2022 - 01/2009
5	Migraine Disorders (Migraine) 01/2022 - 01/2019
5	Reperfusion Injury 01/2021 - 02/2010
5	Neoplasms (Cancer) 12/2020 - 09/2013
4	Brain Infarction 11/2022 - 12/2015
4	Mood Disorders (Mood Disorder) 01/2022 - 09/2010
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 01/2008
4	Neuroblastoma 02/2018 - 09/2002
3	Chronic Pain 02/2021 - 04/2017
3	Nervous System Diseases (Neurological Disorders) 01/2021 - 08/2005
3	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 08/2005
3	Infarction (Infarctions) 01/2016 - 09/2007
2	Cognitive Dysfunction 02/2022 - 01/2019
2	Cancer Pain 04/2017 - 09/2010
2	Inflammation (Inflammations) 03/2016 - 01/2015
2	Hypersensitivity (Allergy) 02/2015 - 02/2013
2	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 01/2008 - 10/2005
2	Seizures (Absence Seizure) 03/2004 - 02/2002
1	Muscle Spasticity (Spastic) 04/2022
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 04/2022
1	COVID-19 02/2022
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 02/2022
1	Headache (Headaches) 01/2022
1	Weight Gain 01/2022
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2022
1	Body Weight (Weight, Body) 01/2022

Drug/Important Bio-Agent (IBA)

18	Volatile Oils (Essential Oils)IBA 01/2022 - 01/2009
11	Retinaldehyde (Retinal)IBA 01/2020 - 10/2005
9	Glutamic Acid (Glutamate)FDA Link 01/2020 - 03/2004
8	Analgesics (Analgesic Drugs)IBA 01/2022 - 09/2013
8	Pharmaceutical PreparationsIBA 07/2020 - 01/2007
7	Neuroprotective AgentsIBA 06/2022 - 08/2005
6	Opioid Analgesics (Opioids)IBA 02/2021 - 04/2017
6	Proteins (Proteins, Gene)FDA Link 12/2020 - 02/2002
6	Azithromycin (Zithromax)FDA LinkGeneric 01/2019 - 01/2016
5	linaloolIBA 09/2013 - 01/2009
4	Antipsychotic Agents (Antipsychotics)IBA 04/2022 - 02/2021
4	Calcitonin Gene-Related PeptideIBA 01/2022 - 01/2019
4	Monoclonal AntibodiesIBA 09/2021 - 01/2019
4	EndocannabinoidsIBA 01/2009 - 07/2007
3	Neurotransmitter Agents (Neurotransmitter)IBA 04/2022 - 05/2012
3	CalciumIBA 01/2022 - 01/2018
3	Tryptamines (Triptans)IBA 09/2021 - 01/2019
3	Gabapentin (Neurontin)FDA LinkGeneric 02/2021 - 01/2020
3	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 01/2011
3	LimoneneIBA 02/2018 - 09/2013
3	Biological ProductsIBA 02/2018 - 02/2010
3	Anti-Bacterial Agents (Antibiotics)IBA 11/2016 - 01/2016
3	MacrolidesIBA 11/2016 - 01/2016
3	CytokinesIBA 01/2016 - 02/2010
3	CannabinoidsIBA 01/2008 - 07/2007
2	AntioxidantsIBA 11/2022 - 01/2020
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 06/2022 - 01/2009
2	eptinezumabIBA 09/2021 - 01/2019
2	5-MethoxypsoralenIBA 03/2021 - 09/2013
2	Antidepressive Agents (Antidepressants)IBA 02/2021 - 01/2019
2	Formaldehyde (Formol)FDA Link 01/2020 - 05/2012
2	mesoglycanIBA 01/2020 - 01/2020
2	Anticonvulsants (Antiepileptic Drugs)IBA 09/2018 - 01/2009
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 09/2018 - 02/2002
2	Sirolimus (Rapamycin)FDA Link 01/2018 - 01/2014
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2017 - 01/2007
2	EnzymesIBA 11/2016 - 01/2016
2	Bexarotene (LGD1069)FDA Link 02/2016 - 12/2015
2	Matrix Metalloproteinases (MMPs)IBA 01/2015 - 01/2009
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2012 - 02/2011
2	anandamide (arachidonylethanolamide)IBA 09/2007 - 07/2007
2	Estrogens (Estrogen)FDA Link 09/2007 - 08/2005
1	Sunflower OilIBA 11/2022
1	Lipid NanoparticlesIBA 01/2022
1	OrexinsIBA 01/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022
1	KATP ChannelsIBA 01/2022
1	PotassiumIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	StearatesIBA 01/2022
1	2-pentadecyl-2-oxazolineIBA 01/2022
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2022
1	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 01/2022
1	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2022
1	2- amino- 4- (3- hydroxy- 5- methylisoxazol- 4- yl)butyric acidIBA 01/2022
1	Furocoumarins (Furanocoumarins)IBA 10/2021

Therapy/Procedure

17	Therapeutics 01/2022 - 01/2008
9	Aromatherapy 01/2022 - 09/2010
7	Ligation 09/2021 - 01/2009
2	Pain Management 02/2022 - 04/2017
1	Analgesia 01/2022
1	Neurological Rehabilitation 01/2022
1	Cognitive Training 01/2022
1	Drug Therapy (Chemotherapy) 01/2022